Actinic keratoses (AK) are precancerous skin lesions that threaten to progress to invasive squamous cell carcinoma (iSCC). AMELUZ® (aminolevulinic acid HCl) topical gel, 10%, with BF-RhodoLED® and RhodoLED® XL, is the first and only combination product for photodynamic therapy approved for field-directed treatment of AK of mild-to-moderate severity on the face and scalp.
The campaign quickly creates a sense of urgency about AKs by leveraging the imagery of sharks circling beneath the surface of a patient’s skin. It reinforces the imminent danger that surrounds visible AKs by memorably demonstrating that while in earlier stages, AK can be easier felt than seen, lesions at any stage, severity, or depth have the potential to progress to iSCC. The brand tells a compelling story of potential danger that will be quickly, safely, and effectively addressed with the adoption of AMELUZ® with BF-RhodoLED® and RhodoLED® XL.
